Literature DB >> 16939750

Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography.

Laura Sangaré1, Michael P Curtis, Shabbir Ahmad.   

Abstract

OBJECTIVES: To evaluate population-based rates of Respiratory Syncytial Virus (RSV)-associated infant hospitalizations related to race/ethnicity, payer source, and geography in California. STUDY
DESIGN: Retrospective analysis of RSV-coded infant hospitalizations were performed using the California patient discharge data for 1999 to 2003. All discharge records for infants younger than 1 year of age with an ICD-9-CM code for any RSV-related illness (466.11, 480.1, or 079.6) among any of the diagnosis fields were selected for analysis (n = 45,330). Rates were expressed as the number of RSV-associated hospitalizations per 1000 live births in the same calendar year.
RESULTS: Infants enrolled in MediCal (California's version of the United States' national Medicaid program) had a relative risk of 2.03 (95% CI, 1.99 to 2.06) compared with non-MediCal payers (24.3 vs 12.0/1000 live births, respectively). The 1999 to 2003 rates per 1000 live births of RSV-associated hospitalizations for MediCal payers by race/ethnicity were: non-Hispanic white (34.9), African-American (27.9), Hispanic (21.8), Asian/Pacific Islander (12.5), and American Indian/Alaska Native (12.2).
CONCLUSIONS: RSV was the leading cause of infant hospitalizations in California between 1999 and 2003. RSV hospitalization rates were highest among non-Hispanic white MediCal insured infants.

Entities:  

Mesh:

Year:  2006        PMID: 16939750     DOI: 10.1016/j.jpeds.2006.04.063

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Human respiratory syncytial virus in children with acute respiratory tract infections in China.

Authors:  Rong-Fang Zhang; Yu Jin; Zhi-Ping Xie; Na Liu; Kun-Long Yan; Han-Chun Gao; Jing-Rong Song; Xin-Hui Yuan; Ni-Guang Xiao; Ming-Wei Guo; Qiong-Hua Zhou; Yun-De Hou; Zhaojun Duan
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

2.  Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.

Authors:  K Grimwood; C Cohet; F J Rich; S Cheng; C Wood; N Redshaw; C W Cunningham; N Pearce; J R Kirman
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

3.  Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010.

Authors:  Kohei Hasegawa; Yusuke Tsugawa; David F M Brown; Jonathan M Mansbach; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

4.  Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005).

Authors:  T M Berger; C Aebi; A Duppenthaler; M Stocker
Journal:  Infection       Date:  2008-12-09       Impact factor: 3.553

5.  Modeling Bronchiolitis Incidence Proportions in the Presence of Spatio-Temporal Uncertainty.

Authors:  Matthew J Heaton; Candace Berrett; Sierra Pugh; Amber Evans; Chantel Sloan
Journal:  J Am Stat Assoc       Date:  2019-05-31       Impact factor: 5.033

6.  Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32-35 Weeks Gestational Age.

Authors:  Jeremy A Franklin; Evan J Anderson; Xionghua Wu; Christopher S Ambrose; Eric A F Simões
Journal:  Open Forum Infect Dis       Date:  2016-07-29       Impact factor: 3.835

Review 7.  Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.

Authors:  Louis Bont; Paul A Checchia; Brigitte Fauroux; Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-08-01

Review 8.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

9.  Respiratory Syncytial Virus Disease Severity in Young Children.

Authors:  Zaid Haddadin; Stockton Beveridge; Kailee Fernandez; Danielle A Rankin; Varvara Probst; Andrew J Spieker; Tiffanie M Markus; Laura S Stewart; William Schaffner; Mary Lou Lindegren; Natasha Halasa
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 20.999

10.  Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.

Authors:  Leonard R Krilov; Anthony S Masaquel; Leonard B Weiner; David M Smith; Sally W Wade; Parthiv J Mahadevia
Journal:  BMC Pediatr       Date:  2014-10-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.